Effective tamoxifen therapy of breast cancer involves both antiproliferative and pro-apoptotic changes

This publication has 25 references indexed in Scilit:

• Tamoxifen for early breast cancer: an overview of the randomised trials
  The Lancet, 1998
• The expression of Ki-S1 and BCL-2 and the response to primary tamoxifen therapy in elderly patients with breast cancer.
  Breast Cancer Research and Treatment, 1997
• Statistics Notes: Measurement error
  BMJ, 1996
• Comparison of the prognostic value of mitotic frequency and Mitotic Activity Index in breast cancer
  The Breast, 1996
• Apoptosis
  Immunology Today, 1993
• HOME: Highly optimized microscope environment
  Cytometry, 1992
• Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death
  Nature, 1990
• Oestrogen receptors in primary and advanced breast cancer: An eight year review of 704 cases
  British Journal of Cancer, 1987
• The value of estrogen and progesterone receptors in the treatment of breast cancer
  Cancer, 1980
• Relation of tumor content of estrogen and progesteron receptors with response of patient to endocrine therapy
  Cancer, 1980